European%20Technology%20Platform%20for%20Global%20Animal%20Health

1
European Technology Platform for Global Animal
Health

• The future
• Interested Parties Meeting
• Brussels
• 31 May 2006
• Jim Scudamore

Acknowledgements Dr Isabel Minguez Tudela DG RTD
2
European Technology Platform for Global Animal
Health

• Organisation

3
European Technology Platform for Global Animal
Health

• Stakeholders
• European Associations relevant to Animal Health
  and Welfare and Food Safety
• IFAH-Europe, COPA-COGECA (farming industry),
  EuropaBio, Diagnostics,
• FVE (Veterinarians), Consumers (BEUC), Eurogroup
  Animal Welfare
• International organizations relevant to Animal
  Health and Welfare and Food Research
  Organizations
• e.g. OIE, FAO, ILRI, GALV
• European Regulatory Authorities
• Heads of Agencies, EMEA, EDQM
• Representatives from the European Research
  Community
• Universities, Institutes, Network of Reference
  Laboratories
• Member State Representations
• CVOs
• European Institutions
• EFSA, European Commission (DG Research, DG SANCO,
  DG Development, DG Enterprise)

4
European Technology Platform for Global Animal
Health

• Timescales
• Vision paper ETP Global Animal Health final
  August 2005
• Strategic Research Agenda final May 2006
• Implementation Plan detailed, roadmap, quantify,
  identify funding sources creation of a financial
  working group

5
European Technology Platform for Global Animal
Health

• Role of the Commission
• The COM is not the  owner  of TPs , nor it is
  directing the way in which they have undertaking
  their activities.
• The COM is encouraging this bottom-up
  industry-led approach to defining medium to long
  term RTD needs.
• - It is actively participating as observer
• - Playing a guiding role where necessary
• - Providing financial support (FP6) for
  operational entities (i.e. secretariat)
• - Sponsoring role through funding
  (collaborative research) in concerned areas

6
European Technology Platform for Global Animal
Health

• Key Factors for Sucess
• Define a  Vision  (common strategy) before
  going further (is it the right approach?)
• Openess (European dimension), participation,
  transparency, communication (essential to get
  consensus, acceptancy and support)
• Consider financial aspects from the beginning
  (mobilise all funding resources including FP7,
  EIB, Eureka, regional funds, private etc..)
• Operational criteria from the beginning (e.g.
  integration of relevant projects, at EU, national
  and regional level)
• Get support from national authorities (follow up
  groups in several TPs)
• Education and training (many reserachers for a
  long period of time)

7
European Technology Platform for Global Animal
Health

• Community support under FP7 for implementing
  SRAs
• Majority of SRAs
• Supported principally through funding schemes for
  collaborative research under the  Cooperation
  Programme 
• Small minority
• Long-term PPP (public-private-partnerships)
  required  Joint Technology Initiatives 

8
Technology Platforms Objectives

• Contribute to Growth Competitiveness(new start
  for the Lisbon strategy COM(2005)24 of 2/2/2005)
• Boost research performance . European Research
  Area . 3 of GDP investment target for RD
• Positive impact on many other key Community
  policies
• Help increase participation of industry in FP7
  and future FPs.

9
European Technology Platform for Global Animal
Health

• Financing RTD in the EU
• FP7 for RTD
• Grants normal cooperative projects
• Credits New Financial Instrument from EIB
  risk-sharing financing facility (RSFF)
• Structural Funds
• Regional cohesion RTD and innovation
• Competitive and Innovation Programme
• Funds for SMEs and creation of enterprises
  (2007-2013)
• European Investment Bank (EIB)
• Initiative  Innovation 2010

10
Strong input from SRAs

• Especially with the goal of increasing
  industrial participation in FP7
• The 7th Framework Programme is tailored to
  better meet industrys needs. Where industrially
  relevant, the definition of work programmes will
  draw on the Strategic Research Agendas developed
  by industry-led technology platforms.
• More detailed account of SRAs will be reflected
  subsequently in- Specific Programmes- Work
  Programmes- Specific Calls for Proposals
• Likely mid-term review of FP7

11
Specific Programmes
FP7 2007 - 2013
Cooperation Collaborative research
Ideas Frontier Research
People Human Potential
Capacities Research Capacity

JRC (non-nuclear)
JRC (nuclear)
Euratom
12
Cooperation Collaborative research

• Thematic Priorities
• Health
• Food, agriculture and biotechnology
• Information and communication technologies
• Nanosciences, nanotechnologies, materials and new
  production technologies
• Energy
• Environment (including climate change)
• Transport (including aeronautics)
• Socio-economic sciences and the humanities
• Security and space
• Euratom Fusion energy research, nuclear
  fission and radiation protection

13
FP7 2007-2013 Food, agriculture and
biotechnology research

• Objectives
• Build a European Knowledge-Based Bio-Economy
  (KBBE)
• Respond to social and economic challenges
• High quality food and sustainable food production
• Food-related disorders (cardiovascular, obesity
  )
• Infectious animal diseases and zoonoses
• Sustainable agriculture/fishery and climate
  change
• Clean biomaterials from renewable bio-resources
• Involve all stakeholders (incl. industry) in
  research
• Support to CAP, CAHP
• Respond quickly to emerging research needs

14
Activity 1
Sustainable production and management of
biological resources from land, forest and
aquatic environments

• Animal welfare, breeding and production
• Exploitation of genetic knowledge, new breeding
  methods
• Animal physiology and behaviour
• Better understanding and control of infectious
  animal diseases, including zoonoses (avian flu,
  BSE etc.)
• Tools for monitoring, prevention and control of
  diseases
• Ecology of known or emerging infectious agents
• Impacts of different farming systems on climate
• Safe disposal of animal waste, improved
  by-product management

15
Ideas Frontier Research
ERC European Research Council
Commission
Scientific Council

• Preparation of work programme
• Set up of peer review pool of reviewers,
  nomination of review panels, evaluation
  guidelines
• Oversight of the evaluation procedure
• Annual scientific report

• Approval of work programme, as defined by the
  Scientific Council
• Instruction to implement work programme
• Approval of annual implementation report
• Information to programme committee

Externalised tasks

• Information and support to applicants
• Reception / eligibility of proposals
• Organisation and execution of evaluation
• Selection decision
• Scientific and financial follow-up of contracts
• Annual implementation report

Created by Commission decision
Under the responsibility of the Commission
16
People Human Potential
Initial training of researchers Marie Curie
Networks
Life-long training and career development Individu
al Fellowships Co-financing of
regional/national/international programmes
Industry-academia pathways and partnerships Indust
ry-Academia Scheme
International dimension Outgoing International
Fellowships Incoming International
Fellowships International Cooperation Scheme
Reintegration grants
Specific actions Excellence awards
17
Capacities Research Capacity
18
Method to develop SRA
Method to develop SRA 2015 Challenges
To discuss
Strategic Research Agenda

Basic research
WG 1
Technology transfer
WG 2
Cooperation Collaborative Research
Capacities Research Capacity
People Human Potential
Ideas Frontier Research

Horizontal issues
WG 3
Vision Global Animal Health
Challenges taken from EU Framework 7
3 Views to address the challenges.
19
Links to Other Platforms or EU Policies

• To prioritise animal diseases,
• CAHP, FAO, OIE, National
• To conduct a gap analyses
• FABR
• To ensure high quality relevant fundamental
  research
• Industrial biotechnology, Innovative medicines,
  FABR, Plant Genomics
• To identify the enabling factors to improve the
  rate of technology transfer
• All
• To consider regulatory issues
• Plant Genomic, innovative medicines, chemistry
• To maintain a global perspective
• None

European Technology Platform for Global Animal
Health
20
Conclusions

• Governance in place
• ETPGAH can further develop the SRA and Action
  Plan
• Monitor progress
• Review regularly
• Action Plan to ensure SRA delivers Vision
• Produce roadmaps milestones
• Secretariat to monitor progress and act as
  necessary

European Technology Platform for Global Animal
Health
21
Conclusions

• Once the prioritisation of diseases and gap
  analyses have commenced, the results will need to
  be reviewed by the platform in order to identify
  and make recommendations to develop specific
  diseases, technology and science programmes to
  fill the gaps.

European Technology Platform for Global Animal
Health
22
Conclusions

• Action Plan to be produced following
  consultations with stakeholders and member states
  authorities. These will complement the vision
  document and the SRA.
• Identify funding sources for the implementation
  of the SRA. This will involve meetings with
  international funders and with the funding
  authorities in the EU and the member states.
• The recommendations in the SRA will need to be
  discussed with all stakeholders to identify who
  will have responsibility and ownership of the
  different components of the SRA.

European Technology Platform for Global Animal
Health
23
Useful links for more information

• CORDIS Web Site
• http//cordis.europa.eu.int/technology-platfor
  ms/home_en.html
• CORDIS partner search http//fp6.cordis.lu/fp6/pa
  rtners.cfm
• Seventh Framework Programmehttp//europa.eu.int/
  comm/research/future/index en.cfm
• IFAH Global Animal Health Platform
• www.ifah.be/europe/euplatform/platform.htm